mirtazapine has been researched along with Heart Failure in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Notably, noradrenergic and specific serotonergic antidepressant (mirtazapine) use was significantly associated with higher prevalence of heart failure (OR 3." | 3.79 | Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population. ( Acharya, S; Acharya, T; Huang, J; Tringali, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loyaga-Rendon, RY | 1 |
| Taylor, DO | 1 |
| Koval, CE | 1 |
| Acharya, T | 1 |
| Acharya, S | 1 |
| Tringali, S | 1 |
| Huang, J | 1 |
2 other studies available for mirtazapine and Heart Failure
| Article | Year |
|---|---|
Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for antibody-mediated rejection.
Topics: Antibodies, Monoclonal, Murine-Derived; Cognition Disorders; Fatal Outcome; Graft Rejection; Heart F | 2013 |
Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Cardiovascular Diseases; Cross-Sectional S | 2013 |